BRIEF—Former FDA manager joins WuXi Biologics as chief quality officer

Hong Kong-listed WuXi Biologics has appointed former US FDA associate country manager Chiang Syin as chief quality officer, responsible for quality assurance, quality control laboratories and regulatory affairs.

Prior to joining the firm, he was a Gates Project International Expert for the Center for Food and Drug Inspection of the China FDA.

Chief executive Chris Chen said: "We are very pleased to welcome Dr Syin to WuXi Bio where his leadership can bring our quality and regulatory organization to a new level."

"Dr Syin's nearly 30 years of experience at US FDA and CFDA biologics quality and compliance will accelerate our path to build a world-class quality organization for biologics commercial manufacturing."